Faculty profile

Jennifer Taher

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Jennifer Taher

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
32 publications in the last five years, latest in 2026.
Senior (last) author on 10 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

143

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Antibody Covid-19 Genomes Genomics Immunity Infection Sars-Cov-2 Serology

Latest papers

Primer part 3 - evaluating, disseminating and sustaining a laboratory quality improvement project.
Clinical biochemistry · 2026 · senior author
Clinically significant DNA variation from the GENCOV and HostSeq COVID-19 genome sequencing studies.
Journal of medical genetics · 2026
The spectrum of copy number variation in the Pan-Canadian HostSeq databank.
PloS one · 2026

All 54 publications

Latest funding

CANCOV2.0: 2-year follow up of the Canadian COVID-19 Prospective Cohort Study
CIHR · 2021 · Co-investigator
$500,000
COVID-19 Variant Supplement - Implementation of serological and molecular tools to inform COVID-19 patient management
CIHR · 2021 · Principal investigator
$50,000
COVID-19 Variant Network - Implementation of serological and molecular tools to inform COVID-19 patient management
CIHR · 2021 · Principal investigator
$100,000

All 5 grants and awards

54 publications.

Primer part 3 - evaluating, disseminating and sustaining a laboratory quality improvement project.

Bohn MK, Augustin R, Chartier LB, Devine L, Doshi S, Ginty L, Lass E, Leung F, Mundle W, Nimmo G, Sandy A, Shillington K, Simon A, Steiman A, Taher A, Friesner CT, Zanchetta C, Taher J

Clinical biochemistry2026Senior author

DOI: 10.1016/j.clinbiochem.2026.111186 PMID: 42669392

Clinically significant DNA variation from the GENCOV and HostSeq COVID-19 genome sequencing studies.

Frangione E, Mahajan R, De Los Rios J, Casalino S, Aujla N, Arnoldo S, Binnie A, Borgundvaag B, Dagher M, Devine L, Faghfoury H, Friedman SM, Fung CYJ, Khan Z, Morgan G, Richardson D, Stern S, Taher A, Taher J, Lerner-Ellis J, GENCOV Study Workgroup, HostSeq Implementation Committee

Journal of medical genetics2026

DOI: 10.1136/jmg-2025-111029 PMID: 41760404

The spectrum of copy number variation in the Pan-Canadian HostSeq databank.

Aujla N, Thiruvahindrapuram B, Casalino S, Frangione E, Mahajan R, Di Iorio D, Fung CYJ, Jayachandran L, MacDonald G, Morgan G, Wolday D, Young J, Arshad M, Clausen M, Arnoldo S, Binnie A, Borgundvaag B, Chowdhary S, Dagher M, Devine L, Friedman SM, Gingras AC, Goneau LW, Khan Z, Lapadula E, Mazzulli T, McGeer A, McLeod S, Mighton C, Pugh TJ, Richardson D, Simpson J, Stern S, Taher A, Strug L, Bombard Y, Faghfoury H, Greenfeld E, CGEn HostSeq Initiative, Scherer SW, Taher J, Noor A, Lerner-Ellis J

PloS one2026

DOI: 10.1371/journal.pone.0359210 PMID: 42789588

Choosing Wisely Canada recommendations for point of care testing utilization in the acute care setting: Expert-based Delphi consensus from the Canadian Society of Clinical Chemists.

Kaur S, Arnoldo S, Taher J, Bailey D, Beach L, Beriault DR, Bouhtiauy I, Brun M, Elnenaei M, Huang Y, Khan AI, Kinniburgh D, Massicotte L, Rezvanpour A, Rodriguez-Capote K, Thakur V, Yip P, Venner AA

Clinical biochemistry2026

DOI: 10.1016/j.clinbiochem.2026.111100 PMID: 41692183

Analytical Imprecision and Therapeutic Intervals for Lithium – Are There Implications for Old Age Patients with Bipolar Disorder?

Zhou J, Tsoukalas D, Chittiprol N, Kavsak P, Leung F, Taher J, Ali-Mohammed Z, Arnoldo S, Tysick H, Fu L

Clinical Biochemistry20263 citations

DOI: 10.1016/j.clinbiochem.2025.111057

Findings from comprehensive genome sequencing in the Canadian population: Results from the GENCOV Study

Casalino S, Aujla N, Frangione E, Mahajan R, Di Iorio D, Fung CYJ, Jayachandran L, MacDonald G, Morgan G, Wolday D

Genetics in Medicine Open2026

DOI: 10.1016/j.gimo.2026.104372

Primer part 2 - implementing a laboratory quality improvement project.

Bohn MK, Augustin R, Chartier LB, Devine L, Doshi S, Ginty L, Lass E, Leung F, Mundle W, Nimmo G, Sandy A, Shillington K, Simon A, Steiman A, Taher A, Friesner CT, Zanchetta C, Taher J

Clinical biochemistry2025Senior author

DOI: 10.1016/j.clinbiochem.2025.110959 PMID: 40544985

Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient care.

Beriault DR, Chen Y, Yip P, Blasutig I, Bhayana V, Rutledge AC, Parker M, Kinniburgh D, Thomas D, Colbourne P, Langman L, Delaney SR, Bennett M, Oleschuk C, Huang Y, Rodriguez-Capote K, Hauff K, Konforte D, Kalra J, Bouhtiauy I, El Hassan MA, Elnenaei M, Thorlacius L, Venner AA, Randell EW, Sohn KY, Leung F, Taher J, Lou A, Arnoldo S, CSCC Utilization Special Interest Group

Clinical biochemistry2025

DOI: 10.1016/j.clinbiochem.2025.110951 PMID: 40409393

Best practice guidelines on reference interval harmonization in Canada: Evidence-based recommendations from the CSCC working group on reference interval harmonization (CSCC WG-hRI)

Bohn MK, Nyholt D, Balion C, Cembrowski G, Collier C, Guire VD, Higgins V, Jung B, Landon O, Mohammed-Ali Z

Clinical Biochemistry20253 citations

DOI: 10.1016/j.clinbiochem.2025.110986

Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study

Morgan G, Fung CYJ, Gingras A-C, Colwill K, Briollais L, Frangione E, Wolday D, Qi F, Pasculescu A, Delgado-Brand M

Clinical Biochemistry20253 citationsSenior author

DOI: 10.1016/j.clinbiochem.2024.110859

CANCOV2.0: 2-year follow up of the Canadian COVID-19 Prospective Cohort Study

Co-investigatorCIHR2021Op. Gr: Emer. COVID Res. Gaps/Prior- Dif. Impacts on Hist. Excl/Underserved Pops

Principal investigators: Herridge, Margaret S; Cheung, Angela M

Keywords: Caregiver Health; Clinical Presentations & Trajectories; Covid-19 Research Gaps; Determinants And Prevalence Of Long-Term Outcomes Of Covid; Functional And Neuropsychological Health & Quality Of Life; Long Covid Serologic, Immunologic & Inflammatory Biomarkers; Longitudinal Study; Mitigating Factors For Disability & Impact Of Rehabilitation; Neurocognitive, Respiratory, Cardiac & Muscle Systems

$500,000

COVID-19 Variant Supplement - Implementation of serological and molecular tools to inform COVID-19 patient management

Principal investigatorCIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 1

Principal investigators: Lerner-Ellis, Jordan P; Taher, Jennifer

Keywords: Antibody; Covid-19; Genomes; Genomics; Immunity; Infection; Sars-Cov-2; Serology; Susceptibility; Virus

$50,000

COVID-19 Variant Network - Implementation of serological and molecular tools to inform COVID-19 patient management

Principal investigatorCIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 2

Principal investigators: Lerner-Ellis, Jordan P; Taher, Jennifer

Keywords: Antibody; Covid-19; Genomes; Genomics; Immunity; Infection; Sars-Cov-2; Serology; Susceptibility; Virus

$100,000

Development of high throughput, inexpensive and scalable testing to detect SARS-CoV-2 antibodies using home blood collection kits and a fully automated ELISA antibody assay

Co-investigatorCIHR2020Operating Grant: COVID-19 Rapid Research Funding Opportunity - Diagnostics

Principal investigators: Jarvi, Keith A; Gingras, Anne-Claude; Mazzulli, Tony

Keywords: Elisa Assays; High Throughput Testing; Immunity; Incidence; Prevalence; Sars-Cov-2 Antibodies; Self Administered Blood Sampling

Implementation of serological and molecular tools to inform COVID-19 patient management

Principal investigatorCIHR2020Op Gr: COVID-19 Rapid Research FO - Clinical Mgmt/Health System Interventions

Principal investigators: Lerner-Ellis, Jordan P; Taher, Jennifer

Keywords: Antibody; Covid-19; Genomes; Genomics; Immunity; Infection; Sars-Cov-2; Serology; Susceptibility; Virus

$2,067,198

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Jennifer Taher

Research

Latest papers

Latest funding

Primer part 3 - evaluating, disseminating and sustaining a laboratory quality improvement project.

Clinically significant DNA variation from the GENCOV and HostSeq COVID-19 genome sequencing studies.

The spectrum of copy number variation in the Pan-Canadian HostSeq databank.

Choosing Wisely Canada recommendations for point of care testing utilization in the acute care setting: Expert-based Delphi consensus from the Canadian Society of Clinical Chemists.

Analytical Imprecision and Therapeutic Intervals for Lithium – Are There Implications for Old Age Patients with Bipolar Disorder?

Findings from comprehensive genome sequencing in the Canadian population: Results from the GENCOV Study

Primer part 2 - implementing a laboratory quality improvement project.

Choosing Wisely Canada recommendations for clinical biochemistry: test ordering for sustainable and high-quality patient care.

Best practice guidelines on reference interval harmonization in Canada: Evidence-based recommendations from the CSCC working group on reference interval harmonization (CSCC WG-hRI)

Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study

CANCOV2.0: 2-year follow up of the Canadian COVID-19 Prospective Cohort Study

COVID-19 Variant Supplement - Implementation of serological and molecular tools to inform COVID-19 patient management

COVID-19 Variant Network - Implementation of serological and molecular tools to inform COVID-19 patient management

Development of high throughput, inexpensive and scalable testing to detect SARS-CoV-2 antibodies using home blood collection kits and a fully automated ELISA antibody assay

Implementation of serological and molecular tools to inform COVID-19 patient management

Frequent collaborators

Khosrow Adeli

Jordan Lerner-Ellis

Yvonne Bombard

Anne-Claude Gingras

Peter Kavsak

Tony Mazzulli

Abdul Noor

Dawit Wolday

Allison McGeer

Vathany Kulasingam

Venkatesh Thiruganasambandamoorthy

Frank Scheuermeyer

Alexandra Binnie

Andrew Worster

Emilie Belley-Cote

Laurent Briollais

Sameer Sharif

Michael Knauer

Howard Chertkow

Davor Brinc

Paul Yip

Neville Suskin

Howard Chertkow

Cynthia Balion

Lucas Chartier

Ivan Blasutig

Rajeevan Selvaratnam

Jing Zhang

Daniel Beriault

Alfonso Fasano

Andrew McRae

Flavia Kessler Borges

Craig Ainsworth

Shawn Mondoux